All Stories

  1. SLD5/GINS4 controls dynein-dependent centrosome maturation and exposes a candidate mitotic vulnerability in cancer
  2. XRRA1 acts as a molecular brake on radiation-induced DNA damage signaling and immunogenic cell death in tumor cells
  3. Role of IGF2BP3 as a prognostic biomarker in chronic myeloid leukemia progression and disease stratification
  4. Cellular autophagy and aging: role in intermittent fasting-induced health benefits
  5. Decoding the Circulating Proteome: Matrix and Immune Context Markers Shape Early Multi-Cancer Detection
  6. Next-generation leukemia diagnostics: Integrating LC-MS/MS proteomics with liquid biopsy platforms
  7. Comprehensive Analysis of Oncogenic Determinants across Tumor Types via Multi-Omics Integration
  8. Inflammation-Driven Tumorigenesis: Mechanisms, Immune Evasion, and Therapeutic Strategies
  9. Role of inflammasomes in cancer immunity: mechanisms and therapeutic potential
  10. AI-Powered Exploration of IGF2BP3 as a Prognostic Biomarker in Chronic Myeloid Leukemia Progression and Disease Stratification
  11. Advancements in High-Performance Liquid Chromatography: Transforming Analytical Chemistry Across Biomedical, Pharmaceutical, and Environmental Domains
  12. Unravelling Neuroinflammation-Mediated Mitochondrial Dysfunction in Mild Cognitive Impairment: Insights from Targeted Metabolomics
  13. Targeting HIF-1α in sickle cell disease and cancer: unraveling therapeutic opportunities and risks
  14. Exploring novel protein biomarkers for early-stage diagnosis and prognosis of T-acute lymphoblastic leukemia (T-ALL)
  15. Expression of CXCL8 (IL-8) in the Pathogenesis of T-Cell Acute Lymphoblastic Leukemia Patients
  16. The Molecular Role of HIF1α Is Elucidated in Chronic Myeloid Leukemia
  17. The bioengineered HALOA complex induces anoikis in chronic myeloid leukemia cells by targeting the BCR-ABL/Notch/Ikaros/Redox/Inflammation axis
  18. Formulation and biophysical characterization of SNARE’s like the behavior of human α-lactalbumin oleic acid (HALOA) complex as an anticancerous agent against chronic myeloid leukemia.
  19. Role of interleukin-8 as a molecular indicator in the pathogenesis of T-cell acute lymphoblastic leukemia (T-ALL)
  20. HALOA a new biotherapeutic agent against CML.
  21. Role of Silent Information Regulator 1 (SIRT1) in Regulating Oxidative Stress and Inflammation